866-997-4948(US-Canada Toll Free)

United States Budesonide (BUD) Market Report 2017

Published By :

QYResearch

Published Date : Jul 2017

Category :

Pharmaceutical

No. of Pages : 108 Pages

In this report, the United States Budesonide (BUD) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Budesonide (BUD) in these regions, from 2012 to 2022 (forecast).

United States Budesonide (BUD) market competition by top manufacturers/players, with Budesonide (BUD) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
AstraZeneca
Cosmo Pharmaceuticals
Teva
Mylan
Sandoz
Dr. Falk Pharma
Chiesi Farmaceutici S.p.A
Orion Corporation
Cipla
Synmosa Biopharma Corporation
Lunan Better Pharmaceutical
Shanghai Sine Promod Pharmaceutical

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Nasal Spray
Inhaler
Pill&Rectal Forms
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Budesonide (BUD) for each application, including
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Budesonide (BUD) Market Report 2017
1 Budesonide (BUD) Overview
1.1 Product Overview and Scope of Budesonide (BUD)
1.2 Classification of Budesonide (BUD) by Product Category
1.2.1 United States Budesonide (BUD) Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Budesonide (BUD) Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Nasal Spray
1.2.4 Inhaler
1.2.5 Pill&Rectal Forms
1.3 United States Budesonide (BUD) Market by Application/End Users
1.3.1 United States Budesonide (BUD) Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Respiratory Disease Treatment
1.3.3 Nose Disease Treatment
1.3.4 Inflammatory Bowel Disease Treatment
1.4 United States Budesonide (BUD) Market by Region
1.4.1 United States Budesonide (BUD) Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Budesonide (BUD) Status and Prospect (2012-2022)
1.4.3 Southwest Budesonide (BUD) Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Budesonide (BUD) Status and Prospect (2012-2022)
1.4.5 New England Budesonide (BUD) Status and Prospect (2012-2022)
1.4.6 The South Budesonide (BUD) Status and Prospect (2012-2022)
1.4.7 The Midwest Budesonide (BUD) Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Budesonide (BUD) (2012-2022)
1.5.1 United States Budesonide (BUD) Sales and Growth Rate (2012-2022)
1.5.2 United States Budesonide (BUD) Revenue and Growth Rate (2012-2022)

2 United States Budesonide (BUD) Market Competition by Players/Suppliers
2.1 United States Budesonide (BUD) Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Budesonide (BUD) Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Budesonide (BUD) Average Price by Players/Suppliers (2012-2017)
2.4 United States Budesonide (BUD) Market Competitive Situation and Trends
2.4.1 United States Budesonide (BUD) Market Concentration Rate
2.4.2 United States Budesonide (BUD) Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Budesonide (BUD) Manufacturing Base Distribution, Sales Area, Product Type

3 United States Budesonide (BUD) Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Budesonide (BUD) Sales and Market Share by Region (2012-2017)
3.2 United States Budesonide (BUD) Revenue and Market Share by Region (2012-2017)
3.3 United States Budesonide (BUD) Price by Region (2012-2017)

4 United States Budesonide (BUD) Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Budesonide (BUD) Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Budesonide (BUD) Revenue and Market Share by Type (2012-2017)
4.3 United States Budesonide (BUD) Price by Type (2012-2017)
4.4 United States Budesonide (BUD) Sales Growth Rate by Type (2012-2017)

5 United States Budesonide (BUD) Sales (Volume) by Application (2012-2017)
5.1 United States Budesonide (BUD) Sales and Market Share by Application (2012-2017)
5.2 United States Budesonide (BUD) Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Budesonide (BUD) Players/Suppliers Profiles and Sales Data
6.1 AstraZeneca
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Budesonide (BUD) Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 AstraZeneca Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Cosmo Pharmaceuticals
6.2.2 Budesonide (BUD) Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Cosmo Pharmaceuticals Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Teva
6.3.2 Budesonide (BUD) Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Teva Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Mylan
6.4.2 Budesonide (BUD) Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Mylan Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Sandoz
6.5.2 Budesonide (BUD) Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Sandoz Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Dr. Falk Pharma
6.6.2 Budesonide (BUD) Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Dr. Falk Pharma Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Chiesi Farmaceutici S.p.A
6.7.2 Budesonide (BUD) Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Chiesi Farmaceutici S.p.A Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Orion Corporation
6.8.2 Budesonide (BUD) Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Orion Corporation Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Cipla
6.9.2 Budesonide (BUD) Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Cipla Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Synmosa Biopharma Corporation
6.10.2 Budesonide (BUD) Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Synmosa Biopharma Corporation Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Lunan Better Pharmaceutical
6.12 Shanghai Sine Promod Pharmaceutical

7 Budesonide (BUD) Manufacturing Cost Analysis
7.1 Budesonide (BUD) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Budesonide (BUD)

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Budesonide (BUD) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Budesonide (BUD) Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Budesonide (BUD) Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Budesonide (BUD) Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Budesonide (BUD) Sales Volume Forecast by Type (2017-2022)
11.3 United States Budesonide (BUD) Sales Volume Forecast by Application (2017-2022)
11.4 United States Budesonide (BUD) Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Budesonide (BUD)
Figure United States Budesonide (BUD) Market Size (K Units) by Type (2012-2022)
Figure United States Budesonide (BUD) Sales Volume Market Share by Type (Product Category) in 2016
Figure Nasal Spray Product Picture
Figure Inhaler Product Picture
Figure Pill&Rectal Forms Product Picture
Figure United States Budesonide (BUD) Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Budesonide (BUD) by Application in 2016
Figure Respiratory Disease Treatment Examples
Table Key Downstream Customer in Respiratory Disease Treatment
Figure Nose Disease Treatment Examples
Table Key Downstream Customer in Nose Disease Treatment
Figure Inflammatory Bowel Disease Treatment Examples
Table Key Downstream Customer in Inflammatory Bowel Disease Treatment
Figure United States Budesonide (BUD) Market Size (Million USD) by Region (2012-2022)
Figure The West Budesonide (BUD) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Budesonide (BUD) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Budesonide (BUD) Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Budesonide (BUD) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Budesonide (BUD) Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Budesonide (BUD) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Budesonide (BUD) Sales (K Units) and Growth Rate (2012-2022)
Figure United States Budesonide (BUD) Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Budesonide (BUD) Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Budesonide (BUD) Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Budesonide (BUD) Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Budesonide (BUD) Sales Share by Players/Suppliers
Figure 2017 United States Budesonide (BUD) Sales Share by Players/Suppliers
Figure United States Budesonide (BUD) Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Budesonide (BUD) Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Budesonide (BUD) Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Budesonide (BUD) Revenue Share by Players/Suppliers
Figure 2017 United States Budesonide (BUD) Revenue Share by Players/Suppliers
Table United States Market Budesonide (BUD) Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Budesonide (BUD) Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Budesonide (BUD) Market Share of Top 3 Players/Suppliers
Figure United States Budesonide (BUD) Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Budesonide (BUD) Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Budesonide (BUD) Product Category
Table United States Budesonide (BUD) Sales (K Units) by Region (2012-2017)
Table United States Budesonide (BUD) Sales Share by Region (2012-2017)
Figure United States Budesonide (BUD) Sales Share by Region (2012-2017)
Figure United States Budesonide (BUD) Sales Market Share by Region in 2016
Table United States Budesonide (BUD) Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Budesonide (BUD) Revenue Share by Region (2012-2017)
Figure United States Budesonide (BUD) Revenue Market Share by Region (2012-2017)
Figure United States Budesonide (BUD) Revenue Market Share by Region in 2016
Table United States Budesonide (BUD) Price (USD/Unit) by Region (2012-2017)
Table United States Budesonide (BUD) Sales (K Units) by Type (2012-2017)
Table United States Budesonide (BUD) Sales Share by Type (2012-2017)
Figure United States Budesonide (BUD) Sales Share by Type (2012-2017)
Figure United States Budesonide (BUD) Sales Market Share by Type in 2016
Table United States Budesonide (BUD) Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Budesonide (BUD) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Budesonide (BUD) by Type (2012-2017)
Figure Revenue Market Share of Budesonide (BUD) by Type in 2016
Table United States Budesonide (BUD) Price (USD/Unit) by Types (2012-2017)
Figure United States Budesonide (BUD) Sales Growth Rate by Type (2012-2017)
Table United States Budesonide (BUD) Sales (K Units) by Application (2012-2017)
Table United States Budesonide (BUD) Sales Market Share by Application (2012-2017)
Figure United States Budesonide (BUD) Sales Market Share by Application (2012-2017)
Figure United States Budesonide (BUD) Sales Market Share by Application in 2016
Table United States Budesonide (BUD) Sales Growth Rate by Application (2012-2017)
Figure United States Budesonide (BUD) Sales Growth Rate by Application (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Budesonide (BUD) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Budesonide (BUD) Sales Growth Rate (2012-2017)
Figure AstraZeneca Budesonide (BUD) Sales Market Share in United States (2012-2017)
Figure AstraZeneca Budesonide (BUD) Revenue Market Share in United States (2012-2017)
Table Cosmo Pharmaceuticals Basic Information List
Table Cosmo Pharmaceuticals Budesonide (BUD) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cosmo Pharmaceuticals Budesonide (BUD) Sales Growth Rate (2012-2017)
Figure Cosmo Pharmaceuticals Budesonide (BUD) Sales Market Share in United States (2012-2017)
Figure Cosmo Pharmaceuticals Budesonide (BUD) Revenue Market Share in United States (2012-2017)
Table Teva Basic Information List
Table Teva Budesonide (BUD) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Budesonide (BUD) Sales Growth Rate (2012-2017)
Figure Teva Budesonide (BUD) Sales Market Share in United States (2012-2017)
Figure Teva Budesonide (BUD) Revenue Market Share in United States (2012-2017)
Table Mylan Basic Information List
Table Mylan Budesonide (BUD) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mylan Budesonide (BUD) Sales Growth Rate (2012-2017)
Figure Mylan Budesonide (BUD) Sales Market Share in United States (2012-2017)
Figure Mylan Budesonide (BUD) Revenue Market Share in United States (2012-2017)
Table Sandoz Basic Information List
Table Sandoz Budesonide (BUD) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sandoz Budesonide (BUD) Sales Growth Rate (2012-2017)
Figure Sandoz Budesonide (BUD) Sales Market Share in United States (2012-2017)
Figure Sandoz Budesonide (BUD) Revenue Market Share in United States (2012-2017)
Table Dr. Falk Pharma Basic Information List
Table Dr. Falk Pharma Budesonide (BUD) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dr. Falk Pharma Budesonide (BUD) Sales Growth Rate (2012-2017)
Figure Dr. Falk Pharma Budesonide (BUD) Sales Market Share in United States (2012-2017)
Figure Dr. Falk Pharma Budesonide (BUD) Revenue Market Share in United States (2012-2017)
Table Chiesi Farmaceutici S.p.A Basic Information List
Table Chiesi Farmaceutici S.p.A Budesonide (BUD) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Chiesi Farmaceutici S.p.A Budesonide (BUD) Sales Growth Rate (2012-2017)
Figure Chiesi Farmaceutici S.p.A Budesonide (BUD) Sales Market Share in United States (2012-2017)
Figure Chiesi Farmaceutici S.p.A Budesonide (BUD) Revenue Market Share in United States (2012-2017)
Table Orion Corporation Basic Information List
Table Orion Corporation Budesonide (BUD) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Orion Corporation Budesonide (BUD) Sales Growth Rate (2012-2017)
Figure Orion Corporation Budesonide (BUD) Sales Market Share in United States (2012-2017)
Figure Orion Corporation Budesonide (BUD) Revenue Market Share in United States (2012-2017)
Table Cipla Basic Information List
Table Cipla Budesonide (BUD) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cipla Budesonide (BUD) Sales Growth Rate (2012-2017)
Figure Cipla Budesonide (BUD) Sales Market Share in United States (2012-2017)
Figure Cipla Budesonide (BUD) Revenue Market Share in United States (2012-2017)
Table Synmosa Biopharma Corporation Basic Information List
Table Synmosa Biopharma Corporation Budesonide (BUD) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Synmosa Biopharma Corporation Budesonide (BUD) Sales Growth Rate (2012-2017)
Figure Synmosa Biopharma Corporation Budesonide (BUD) Sales Market Share in United States (2012-2017)
Figure Synmosa Biopharma Corporation Budesonide (BUD) Revenue Market Share in United States (2012-2017)
Table Lunan Better Pharmaceutical Basic Information List
Table Shanghai Sine Promod Pharmaceutical Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Budesonide (BUD)
Figure Manufacturing Process Analysis of Budesonide (BUD)
Figure Budesonide (BUD) Industrial Chain Analysis
Table Raw Materials Sources of Budesonide (BUD) Major Players/Suppliers in 2016
Table Major Buyers of Budesonide (BUD)
Table Distributors/Traders List
Figure United States Budesonide (BUD) Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Budesonide (BUD) Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Budesonide (BUD) Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Budesonide (BUD) Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Budesonide (BUD) Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Budesonide (BUD) Sales Volume (K Units) Forecast by Type in 2022
Table United States Budesonide (BUD) Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Budesonide (BUD) Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Budesonide (BUD) Sales Volume (K Units) Forecast by Application in 2022
Table United States Budesonide (BUD) Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Budesonide (BUD) Sales Volume Share Forecast by Region (2017-2022)
Figure United States Budesonide (BUD) Sales Volume Share Forecast by Region (2017-2022)
Figure United States Budesonide (BUD) Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *